Literature DB >> 21913989

Brain magnetic resonance angiography in splenectomized adults with β-thalassemia intermedia.

Khaled M Musallam1, Ahmad Beydoun, Roula Hourani, Wassim Nasreddine, Roy Raad, Suzanne Koussa, Ali T Taher.   

Abstract

BACKGROUND: Hypercoagulability and venous thromboembolism are common in patients with β-thalassemia intermedia (TI), especially in the splenectomized adult. Although arterial involvement is not commonly reported, we have recently observed a high prevalence (60%) of silent brain infarction on brain MRI in 30 splenectomized adults with TI. The pathophysiology of these white matter lesions remains unknown.
METHODS: In this prospective work, we evaluated magnetic resonance angiography (MRA) scans of the same cohort of 30 patients. Data collected were the presence or absence of vascular lesions, their locations, and severity. Correlations between MRA abnormality and patients/disease characteristics were evaluated. Comparisons between MRA and previous MRI findings were made.
RESULTS: Of 29 evaluable patients, 8 (27.6%) had evidence of arterial stenosis on MRA. The majority of lesions had mild narrowing and mostly involved the internal carotid artery. Five patients (17.2%) had evidence of aneurysms. Low total hemoglobin and high non-transferrin-bound iron levels independently characterized patients with evidence of stenosis on MRA. Among the 18 patients with silent brain infarction on MRI, three had evidence of stenosis on MRA with only one patient having lesions that could explain the silent infarcts.
CONCLUSIONS: Cerebral vasculopathy is common in splenectomized adults with TI. However, large-vessel disease does not explain the occurrence of silent brain infarction. The combined use of MRA and MRI better identifies splenectomized TI adults with neuroimaging abnormalities.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21913989     DOI: 10.1111/j.1600-0609.2011.01706.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  16 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 2.  Management of non-transfusion-dependent thalassemia: a practical guide.

Authors:  Ali T Taher; Maria Domenica Cappellini
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

Review 3.  Iron overload in thalassemia: different organs at different rates.

Authors:  Ali T Taher; Antoine N Saliba
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Ivy sign in mildly symptomatic β-thalassemia intermedia, with development of moyamoya disease.

Authors:  Ahmed H El Beltagi; Ahmed El-Sheikh; Reem El-Saif; Alexander Norbash
Journal:  Neuroradiol J       Date:  2014-02-24

5.  FUNCTIONAL CONNECTIVITY ANALYSIS FOR THALASSEMIA DISEASE BASED ON A GRAPHICAL LASSO MODEL.

Authors:  Julie Coloigner; Ronald Phlypo; Adam Bush; Natasha Lepore; John Wood
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2016-06-16

Review 6.  Non-transfusion-dependent thalassemias.

Authors:  Khaled M Musallam; Stefano Rivella; Elliott Vichinsky; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

7.  Cerebral venous sinus thrombosis and aneurysm in a patient with double heterozygous beta-thalassemia major: A case report.

Authors:  Rui Gu; Yao Xiong; Li Li; Xiaoling Zhao; Yan Liu
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

8.  The vascular phenotype in Pseudoxanthoma elasticum and related disorders: contribution of a genetic disease to the understanding of vascular calcification.

Authors:  Georges Lefthériotis; Loukman Omarjee; Olivier Le Saux; Daniel Henrion; Pierre Abraham; Fabrice Prunier; Serge Willoteaux; Ludovic Martin
Journal:  Front Genet       Date:  2013-02-12       Impact factor: 4.599

Review 9.  Treating iron overload in patients with non-transfusion-dependent thalassemia.

Authors:  Ali T Taher; Vip Viprakasit; Khaled M Musallam; M Domenica Cappellini
Journal:  Am J Hematol       Date:  2013-03-08       Impact factor: 10.047

10.  Prevalence and Risk Factors for Complications in Patients with Nontransfusion Dependent Alpha- and Beta-Thalassemia.

Authors:  Poramed Winichakoon; Adisak Tantiworawit; Thanawat Rattanathammethee; Sasinee Hantrakool; Chatree Chai-Adisaksopha; Ekarat Rattarittamrong; Lalita Norasetthada; Pimlak Charoenkwan
Journal:  Anemia       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.